News, Analysis & Insights on Nutrition, Supplements, and Health
Health product manufacturer TSI Group has announced the approval of the first ever China Food and Drug Administration (CFDA) Manufacturing Licence for β-hydroxy β-methylbutyrate (HMB) production in China.
A disagreement between researchers and an ingredient supplier about the import of recent carotenoid research raised again the sticky question of when processing steps might convert a natural ingredient into an artificial one.
Preterm infants given the highest daily doses of vitamin D3 saw significant reductions in deficiency prevalence, say researchers.
A new Health Canada ‘no objections letter’ expands manufacturers’ flexibility to formulate and market products with Ganeden’s branded Bacillus cogulans GBI-30, 6086 (or GanedenBC30 for short) in Canada. This includes leeway to use less than 1 billion CFU...
Oral ingestion of Aquamin—a form of calcium derived from calcified red marine algae—may lead to less deterioration of the trabecular bone structure, according to a team of researchers from various institutions in Ireland.
A lack of identity testing is a frequent failure cited in warning letters issued by the Food and Drug Administration. But even when tests are being done, they need to be done in the right way and with properly calibrated equipment.
Tackling malnutrition in American hospitals could help save millions of dollars by shortening hospital stays and lowering readmission rates, says a new study conducted in four Chicago area hospitals.